42 Hayarkon Street
Yavne 8122745
Israel
972 7 797 14100
https://www.mediwound.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 100
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Ofer Gonen B.Sc. | Chief Executive Officer | 649k | N/A | 1973 |
Ms. Hani Luxenburg | Chief Financial Officer | 235k | N/A | 1973 |
Dr. Lior Rosenberg M.D. | Co-Founder | 727k | N/A | 1946 |
Dr. Shmulik Hess Ph.D. | COO & Chief Commercial Officer | N/A | N/A | 1973 |
Mr. Yaron Meyer Adv. | Executive VP, General Counsel & Corporate Secretary | 240k | N/A | 1979 |
Mr. Barry J. Wolfenson | Executive Vice President of Strategy & Corporate Development | N/A | N/A | 1967 |
Dr. Ety Klinger MBA, Ph.D. | Chief Research & Development Officer | 393k | N/A | 1962 |
Dr. Robert J. Snyder CWS, D.P.M., F.A.C.F.A.S., FFPM, M.B.A., M.Sc. | Chief Medical Officer | N/A | N/A | 1950 |
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; and MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
MediWound Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.